H. Eriksson, K. Wåhlander, D. Gustafsson, L.t Welin, L. Frison, S. Schulman and for the thrive investigators A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I Journal of Thrombosis and Haemostasis 1
Article first published online: 3 JAN 2003 | DOI: 10.1046/j.1538-7836.2003.00034.x
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.